Literature DB >> 24442233

Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study.

Erin M Kahle1, Angela Kashuba, Jared M Baeten, Kenneth H Fife, Connie Celum, Andrew Mujugira, Max Essex, Guy De Bruyn, Anna Wald, Deborah Donnell, Grace John-Stewart, Sinead Delany-Moretlwe, Nelly R Mugo, Carey Farquhar, Jairam R Lingappa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24442233      PMCID： PMC3898592          DOI： 10.1097/QAI.0b013e3182a2db02

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  17 in total

1.  Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda.

Authors:  R H Gray; M J Wawer; R Brookmeyer; N K Sewankambo; D Serwadda; F Wabwire-Mangen; T Lutalo; X Li; T vanCott; T C Quinn
Journal:  Lancet       Date:  2001-04-14       Impact factor: 79.321

2.  Simultaneous determination of six HIV nucleoside analogue reverse transcriptase inhibitors and nevirapine by liquid chromatography with ultraviolet absorbance detection.

Authors:  Naser L Rezk; Richard R Tidwell; Angela D M Kashuba
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-07-05       Impact factor: 3.205

3.  Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda.

Authors:  Eugene Ruzagira; Symon Wandiembe; Leonard Bufumbo; Jonathan Levin; Matthew A Price; Heiner Grosskurth; Anatoli Kamali
Journal:  Trop Med Int Health       Date:  2009-01-15       Impact factor: 2.622

4.  Payment of clinical research subjects.

Authors:  Christine Grady
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

5.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

Authors:  T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

6.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

7.  Motivations for participating in an HIV vaccine efficacy trial.

Authors:  Grant Colfax; Susan Buchbinder; Goli Vamshidar; Connie Celum; David McKirnan; Judith Neidig; Beryl Koblin; Marc Gurwith; Brad Bartholow
Journal:  J Acquir Immune Defic Syndr       Date:  2005-07-01       Impact factor: 3.731

8.  Experiences in conducting multiple community-based HIV prevention trials among women in KwaZulu-Natal, South Africa.

Authors:  Gita Ramjee; Nicola Coumi; Nozizwe Dladla-Qwabe; Shay Ganesh; Sharika Gappoo; Roshini Govinden; Vijayanand Guddera; Rashika Maharaj; Jothi Moodley; Neetha Morar; Sarita Naidoo; Thesla Palanee
Journal:  AIDS Res Ther       Date:  2010-04-23       Impact factor: 2.250

9.  Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk.

Authors:  Jairam R Lingappa; James P Hughes; Richard S Wang; Jared M Baeten; Connie Celum; Glenda E Gray; Wendy S Stevens; Deborah Donnell; Mary S Campbell; Carey Farquhar; M Essex; James I Mullins; Robert W Coombs; Helen Rees; Lawrence Corey; Anna Wald
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

Review 10.  Pharmacokinetic properties of nucleoside/nucleotide reverse transcriptase inhibitors.

Authors:  Peter J Piliero
Journal:  J Acquir Immune Defic Syndr       Date:  2004-09-01       Impact factor: 3.731
View more
  30 in total

1.  High Rates of Baseline Drug Resistance and Virologic Failure Among ART-naive HIV-infected Children in Mali.

Authors:  Claudia S Crowell; Almoustapha I Maiga; Mariam Sylla; Babafemi Taiwo; Niaboula Kone; Assaf P Oron; Robert L Murphy; Anne-Geneviève Marcelin; Ban Traore; Djeneba B Fofana; Gilles Peytavin; Ellen G Chadwick
Journal:  Pediatr Infect Dis J       Date:  2017-11       Impact factor: 2.129

Review 2.  Deception in clinical trials and its impact on recruitment and adherence of study participants.

Authors:  Chuen Peng Lee; Tyson Holmes; Eric Neri; Clete A Kushida
Journal:  Contemp Clin Trials       Date:  2018-08-21       Impact factor: 2.226

3.  Genital Herpes Simplex Virus Type 2 Shedding Among Adults With and Without HIV Infection in Uganda.

Authors:  Warren Phipps; Edith Nakku-Joloba; Elizabeth M Krantz; Stacy Selke; Meei-Li Huang; Fred Kambugu; Jackson Orem; Corey Casper; Lawrence Corey; Anna Wald
Journal:  J Infect Dis       Date:  2015-10-20       Impact factor: 5.226

4.  Low-level Viremia early in HIV infection.

Authors:  Iris Chen; Vanessa Cummings; Jessica M Fogel; Mark A Marzinke; William Clarke; Matthew B Connor; Sam Griffith; Susan Buchbinder; Steven Shoptaw; Carlos Del Rio; Manya Magnus; Sharon Mannheimer; Darrell P Wheeler; Kenneth H Mayer; Beryl A Koblin; Susan H Eshleman
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-01       Impact factor: 3.731

5.  Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study.

Authors:  Sunil Suhas Solomon; Shruti H Mehta; Allison M McFall; Aylur K Srikrishnan; Shanmugam Saravanan; Oliver Laeyendecker; Pachamuthu Balakrishnan; David D Celentano; Suniti Solomon; Gregory M Lucas
Journal:  Lancet HIV       Date:  2016-03-11       Impact factor: 12.767

6.  Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial.

Authors:  Rami Kantor; Laura Smeaton; Saran Vardhanabhuti; Sarah E Hudelson; Carol L Wallis; Srikanth Tripathy; Mariza G Morgado; Shanmugham Saravanan; Pachamuthu Balakrishnan; Marissa Reitsma; Stephen Hart; John W Mellors; Elias Halvas; Beatriz Grinsztejn; Mina C Hosseinipour; Johnstone Kumwenda; Alberto La Rosa; Umesh G Lalloo; Javier R Lama; Mohammed Rassool; Breno R Santos; Khuanchai Supparatpinyo; James Hakim; Timothy Flanigan; Nagalingeswaran Kumarasamy; Thomas B Campbell; Susan H Eshleman
Journal:  Clin Infect Dis       Date:  2015-02-13       Impact factor: 9.079

7.  Brief Report: Medication Sharing Is Rare Among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention.

Authors:  Kerry A Thomson; Jessica E Haberer; Mark A Marzinke; Andrew Mujugira; Craig W Hendrix; Connie Celum; Patrick Ndase; Allan Ronald; David R Bangsberg; Jared M Baeten
Journal:  J Acquir Immune Defic Syndr       Date:  2017-06-01       Impact factor: 3.731

8.  Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061.

Authors:  Iris Chen; Matthew B Connor; William Clarke; Mark A Marzinke; Vanessa Cummings; Autumn Breaud; Jessica M Fogel; Oliver Laeyendecker; Sheldon D Fields; Deborah Donnell; Sam Griffith; Hyman M Scott; Steven Shoptaw; Carlos del Rio; Manya Magnus; Sharon Mannheimer; Darrell P Wheeler; Kenneth H Mayer; Beryl A Koblin; Susan H Eshleman
Journal:  J Acquir Immune Defic Syndr       Date:  2015-08-01       Impact factor: 3.731

9.  Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection.

Authors:  Mark A Marzinke; William Clarke; Lei Wang; Vanessa Cummings; Ting-Yuan Liu; Estelle Piwowar-Manning; Autumn Breaud; Sam Griffith; Susan Buchbinder; Steven Shoptaw; Carlos del Rio; Manya Magnus; Sharon Mannheimer; Sheldon D Fields; Kenneth H Mayer; Darrell P Wheeler; Beryl A Koblin; Susan H Eshleman; Jessica M Fogel
Journal:  Clin Infect Dis       Date:  2013-10-02       Impact factor: 9.079

10.  Undisclosed antiretroviral drug use in Botswana: implication for national estimates.

Authors:  Sikhulile Moyo; Simani Gaseitsiwe; Kathleen M Powis; Molly Pretorius Holme; Terence Mohammed; Melissa Zahralban-Steele; Etienne K Yankinde; Comfort Maphorisa; William Abrams; Refeletswe Lebelonyane; Kutlo Manyake; Tumalano Sekoto; Mompati Mmalane; Tendani Gaolathe; Kathleen E Wirth; Joseph Makhema; Shahin Lockman; William Clarke; Max Essex; Vlad Novitsky
Journal:  AIDS       Date:  2018-07-17       Impact factor: 4.177
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.